Acton Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.40 M
- Revenue Growth 30.63%
- Profit Growth 16.77%
- Ebitda -2.53%
- Net Worth 32.31%
- Total Assets 48.15%
About Acton Pharma
Acton Pharma Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 May 2012 and has a history of 12 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.40 M.
Vikas Tyagi and Pavan Tyagi serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2012PTC235869
-
Company No.
235869
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 May 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Acton Pharma Private Limited offer?
Acton Pharma Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Dry Syrups, Pain Killers, Pain Relief Tablet.
Who are the key members and board of directors at Acton Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Tyagi
|
Director | 15-May-2012 | Current |
|
Pavan Tyagi
|
Director | 15-May-2012 | Current |
Financial Performance of Acton Pharma.
Acton Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 30.63% increase. The company also saw a substantial improvement in profitability, with a 16.77% increase in profit. The company's net worth Soared by an impressive increase of 32.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acton Pharma?
Unlock access to Acton Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
1St Rate Pharma Private LimitedVikas Tyagi is a mutual person
-
Acton Finvest Private LimitedVikas Tyagi and Pavan Tyagi are mutual person
Charges (Loans)
₹9.40 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.94 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2024 | Others | ₹9.40 M | Open |
How Many Employees Work at Acton Pharma?
Unlock and access historical data on people associated with Acton Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acton Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acton Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.